Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

British fund manager Terry Smith has sold his stake in Diageo Plc, citing concerns about the management of the drinks company and its vulnerability to soaring demand for weight-loss drugs.

The dominance of the US, and its technology companies in particular, has become an accepted feature of global stock markets.

Novo Nordisk has expanded its partnership with Valo Health to advance new therapies for type 2 diabetes, obesity and ...